Newsletter | November 17, 2026

11.17.26 -- Advancing Small Molecule Manufacturing

 

 

Advancing small molecule programs from drug substance development through drug product manufacturing requires more than strong science. Success depends on integrated strategies that connect process development, scale-up, manufacturing, and formulation innovation to support quality, efficiency, and long-term commercial readiness.

 

Organizations must balance evolving technical, operational, and regulatory demands while optimizing both active pharmaceutical ingredient (API) production and finished dosage form development. From enhancing manufacturing performance and supply chain resilience to implementing innovative drug product technologies, aligning these capabilities can help accelerate timelines, reduce risk, and support successful product launches.

 

Discover practical approaches for strengthening drug substance and drug product development in this edition of the Outsourced Pharma Capabilities Update. Watch the presentations below to gain valuable insights for your next manufacturing, formulation, and commercialization initiative.

 

Recent Sessions Available On-Demand                                   
 Navigating The Complexities Of ADC Development And Manufacturing – October 2026                               
 Turning Fill/Finish Complexity Into Commercial Readiness – October 2026                               
 mRNA Manufacturing And Packaging Strategies – October 2026                               
 Advancing the Future Of Drug Development – October 2026                        

 

Upcoming OPCU Topics & Times                 
 Enabling ADC Success | 12/1/2026, PM Session                                 
 Mastering Aseptic Fill-Finish | 12/1/2026, PM Session                          

 

Access more on-demand OPCU recordings and upcoming sessions here.

SMALL MOLECULE DRUG SUBSTANCE

Siegfried

We support small molecules from development through commercialization with scalable processes and a global network built for reliable, secure supply.

Request Information

Siegfried

Flamma

Watch how emerging technologies and sustainable methodologies are transforming API and peptide manufacturing, improving process efficiency, and strengthening complex supply chains for future pharmaceutical development success.

Request Information

Flamma

SK Pharmteco

Backed by decades of experience and a proven track record of quality, this organization deliver programs from early-phase to commercial manufacturing.

Request Information

SK pharmteco

Novartis Contract Manufacturing

Scaling small molecule production requires flexibility, specialized chemistry, and seamless technology transfer. Successful commercialization depends on robust project governance and rigorous safety standards to navigate manufacturing environments.

Request Information

Novartis Contract Manufacturing

SMALL MOLECULE DRUG PRODUCT

Morpho Alfasigma

Scale-up small molecule therapies with seamless tech transfer, regulatory alignment, and commercial manufacturing expertise for reliable, high-quality drug delivery.

Request Information

Morpho Alfasigma

Rottendorf Pharma GmbH

Optimize oral solid dose development with scalable formulations, robust process engineering, and integrated supply networks that accelerate scale-up and ensure reliable market delivery.

Request Information

Rottendorf Pharma GmbH

Bora Pharmaceuticals

Simplify outsourcing across diverse pipelines with flexible dosage-form capabilities, scalable capacity, and support from clinical development to commercial supply.

Request Information

Bora Pharmaceuticals